JAK Inhibitor Potential in Systemic Sclerosis-Associated ILD The occurrence of interstitial lung disease (ILD) in Syste
Tweet Content
JAK Inhibitor Potential in Systemic Sclerosis-Associated ILD
The occurrence of interstitial lung disease (ILD) in Systemic sclerosis portends serious morbid and mortal outcomes for those affected.
https://t.co/I1TCG3AtaW https://t.co/T7r2VKBPhG
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off